Skip to main content
Premium Trial:

Request an Annual Quote

Wellcome Trust Threatens to Stop Funding Infrastructure Projects

CAMBRIDGE, UK, April 5 – The director of the Wellcome Trust has threatened to halt funding for the building of new research centers and said he would call on Britain’s next government to increase state funding for science.

“The medical research charities were not established to invest in equipment or bricks and mortar, but that is exactly what the lack of state funding has led us to do in recent years,” said Mark Dexter, head of the Wellcome Trust, which funded one-third of the Human Genome Project.

Charitable givers “will, rightly, not tolerate their gift being spent on things that are clearly the responsibility of the state. Charities should not become a substitute for adequate state investment,” he said.

The trust invested £300 million ($429.8 million) last year in infrastructure and has committed another £225 million this year to make up for what it sees as decades of neglect. Twenty-three percent of all British research and development funding now comes from charities, compared with just nine percent in the United States. 

But Dexter, who spoke at the Save British Science Society Wednesday night in London, told the society that the trust would not make any new commitments to fund buildings for scientific research.

Dexter’s decision to cut funding for infrastructure projects could have an impact on a proposal made by the trust last year to expand its genome research facilities in the UK. Plans to increase the size of the Wellcome Trust Genome Campus have been held up due to the government’s initial refusal to grant permission to enlarge the facilities, on the outskirts of Cambridge. 

“With some prodding and hundreds of millions of pounds from the medical research charities, the present government has done more to rebuild the UK science base than any other in recent years,” Dexter said. “My message is that there is much more to do and the next government will need to ensure that sustaining the competitiveness of British science is a national priority.”

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.